Ying Wang, Ph.D. | Center for Discovery and Innovation NJ

Wang Lab

Ying Wang, Ph.D.
Research Assistant Member, Center for Discovery and Innovation

Dr. Wang is a Research Assistant Member at the Center for Discovery and Innovation. Dr. Wang received her Ph.D. in Neuropharmacology from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and completed postdoctoral training at Temple University, where she investigated mechanisms of neurological disorders before transitioning into T cell immunology.

Dr. Wang’s current research focuses on how calcium signals orchestrate with epigenetic regulation to control T cell function in immune-mediated diseases and cancer. Specifically, her work has centered to identify the role of distinct calcium channels in regulating the molecular programs that govern T cell differentiation trajectory, thereby determining long-term functional durability in the context of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and CAR-T cell therapy.

Dr. Wang identified Id3, a transcriptional regulator, coordinated gene programs that sustain progenitor-like alloreactive T cells and drive graft-versus-host disease (GVHD) in peripheral tissues, opening new opportunities to selectively reduce tissue-specific GVHD without causing systemic adverse effects. Her recent research demonstrated that (accepted in Cellular & Molecular Immunology) defines a non-canonical EZH2 mechanism that suppresses Ca²⁺ signaling in alloreactive T cells. Targeting this the EZH2-Ca²⁺ axis offers a dual-pronged approach for mitigating GVHD and enhancing CAR-T cell functionality. Building on these studies, Dr. Wang has recently identified a mitochondrial calcium channel MCU as a central regulator of T cell stemness and pathogenicity in T cell alloimmunity, providing a new therapeutic strategy to selectively eliminate pathogenic T cell alloreactions while preserving protective immunity.

Dr. Wang’s long-term goal is to translate mechanistic insights into clinically actionable strategies to improve outcomes of allo-HSCT as well as T cell-mediated immunotherapies and diseases.

Contact the Lab

Phone: 201-880-3492
Email
: Yingx.Wang@hmh-cdi.org

Mailing Address:
Center for Discovery and Innovation
Room 5519, Lab #5516
111 Ideation Way
Nutley, NJ 07110


Pubmed

Cookie Consent

Our website uses cookies. Please review our Privacy Policy to find out more about the cookies we use. Browsing our website means you accept these terms.